BOFAS News & Events

This pages lists all the latest news and upcoming events.

 

To access 'Foot Print' (the BOFAS Bulletin) please click here (members only)

 

Latest News

EFAS Lyon 2021 - Hybrid Annual Meeting

October 21-22-23 - Combined Face to Face and Virtual Meeting

The EFAS Congress Lyon 2021 will be the first hybrid congress from the European Foot and Ankle Society. 

EFAS hopes BOFAS members and others will join them in person for 3 amazing days of congress, to meet each other and exchange ideas, but in the current climate going abroad might still be difficult. EFAS would therefore like to extend the opportunity for all to be part of the congress by going HYBRID for the first time. 

12345678

 

BOFAS Hosted Events

BOFAS Principles Course - Dubai

The aim is to give Overseas Trainee Orthopaedic Surgeons a solid grounding in the principles and the decision making in Foot & Ankle Surgery.

There is an emphasis on clinical examination of cases, small group discussions and learning surgical approaches in the cadaver lab.

This is the first course BOFAS is running in UAE and the aim is to expand the Foot and Ankle education and training in the Middle East and Gulf area.

Venue - Le Meridien, Dubai, United Arab Emirates

Documents to download

BOFAS Principles Course Taunton

These courses are aimed at Higher Surgical Trainees / ST3 onwards and are designed to teach the core of Foot and Ankle surgery in an informal and interactive environment. The emphasis is on clinical examination cases, discussion groups and typical day-to-day clinic scenarios. Although not an exam preparation course, content is taught to the standard expected in the FRCS(Tr & Orth) exam; that of a day-one non-specialist orthopaedic consultant. Applications will open on 1st September 2023.

Venue - Taunton (TBC)

 

 

Documents to download


 

BOFAS Affiliated Courses

Other External Events / Courses

Togay Koç
/ Categories: Abstracts, 2017, Podium

Total ankle replacement: 6 year survivorship of 118 consecutive Zenith Ankle replacements from a non-designer centre

J. Ring, J. Davenport, M. Karski, R. Smith, H. Divercha, T. Clough

Introduction: Traditional treatment for end-stage ankle arthritis has been ankle arthrodesis, however ankle arthroplasty is becoming an accepted alternative. The Zenith Ankle (Corin, UK) is 3rd generation implant with a mobile bearing design. In the NJR 2016 report, the Zenith was the commonest ankle prosthesis implanted in the UK. However, compared to other ankle implants, there's little published data on its performance and survival. The aim of this study was to analyse outcome in a consecutive series from a non-designer centre.

Method: We conducted a retrospective review of a consecutive series of 118 Zenith Ankle replacements implanted in our Unit (December 2010 to May 2016). Data was collected from our National Joint Registry entries, research databases, patient notes, PACS and PROMS.

Results: Average age was 68.2 years (range 46-86 years; 75M:43F; 97 Osteoarthritis, 20 inflammatory arthritis, 1 haemophilia). Results show a 95.8% survivorship at average 3.5 years follow up (range 0.6-6.3 years). 5 patients (4.2%) required revision. Average pre- and post-op MOXFQ scores were 85.0/100 and 32/100 respectively with improvements in VAS from 7.0/10 to 3.6/10, with an average range of movement of 20.4 degrees. Overall satisfaction rate was 89%. There were 65 complications in 55 patients, but only 7.7% of these led to detrimental effects on the implant. The commonest were malleolar fracture (14.4%), wound problems (13.6%) and superficial infection (12.7%), medial gutter pain (10.2%). There were no cases of deep infection. Five patients required revision (all were revised to revision arthroplasty), for component loosening, or pain and stiffness.

Conclusions: This is largest non-designer centre series examining the outcomes of the Zenith implant. Survival figures for this implant are comparable to NJR averages (6.8% revision at 5 years), with high levels of patient functional outcome and satisfaction. The data highlights the risks associated with this procedure.

Print
769